Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of NeuroEngineering and Rehabilitation
Published in: Journal of NeuroEngineering and Rehabilitation 1/2018

Open Access 01-12-2018 | Research

Mechanisms of electrical vasoconstriction

Authors: Mark Brinton, Yossi Mandel, Ira Schachar, Daniel Palanker

Published in: Journal of NeuroEngineering and Rehabilitation | Issue 1/2018

Login to get access

Abstract

Background

Electrical vasoconstriction is a promising approach to control blood pressure or restrict bleeding in non-compressible wounds. We explore the neural and non-neural pathways of electrical vasoconstriction in-vivo.

Methods

Charge-balanced, asymmetric pulses were delivered through a pair of metal disc electrodes. Vasoconstriction was assessed by measuring the diameter of rat saphenous vessels stimulated with low-voltage (20 V, 1 ms) and high-voltage (150 V, 10 μs) stimuli at 10 Hz for 5 min. Activation pathways were explored by topical application of a specific neural agonist (phenylephrine, alpha-1 receptor), a non-specific agonist (KCl) and neural inhibitors (phenoxybenzamine, 25 mg/ml; guanethidine, 1 mg/ml). Acute tissue damage was assessed with a membrane permeability (live-dead) fluorescent assay. The Joule heating in tissue was estimated using COMSOL Multiphysics modeling.

Results

During stimulation, arteries constricted to 41 ± 8% and 37 ± 6% of their pre-stimulus diameter with low- and high-voltage stimuli, while veins constricted to 80 ± 18% and 40 ± 11%, respectively. In arteries, despite similar extent of constriction, the recovery time was very different: about 30 s for low-voltage and 10 min for high-voltage stimuli. Neural inhibitors significantly reduced low-voltage arterial constriction, but did not affect high-voltage arterial or venous constriction, indicating that high-voltage stimuli activate non-neural vasoconstriction pathways. Adrenergic pathways predominantly controlled low-voltage arterial but not venous constriction, which may involve a purinergic pathway. Viability staining confirmed that stimuli were below the electroporation threshold. Modeling indicates that heating of the blood vessels during stimulation (< 0.2 °C) is too low to cause vasoconstriction.

Conclusions

We demonstrate that low-voltage stimuli induce reversible vasoconstriction through neural pathways, while high-voltage stimuli activate non-neural pathways, likely in addition to neural stimulation. Different stimuli providing precise control over the extent of arterial and venous constriction as well as relaxation rate could be used to control bleeding, perfusion or blood pressure.
Literature
1.
Mandel Y, et al. “Vasoconstriction by electrical stimulation: new approach to control of non-compressible hemorrhage,” (in eng). Sci Rep. 2013;3:2111.CrossRefPubMedPubMedCentral
2.
Brinton MR, Mandel Y, Dalal R, Palanker D. “Miniature electrical stimulator for hemorrhage control,” (in eng). IEEE Trans Biomed Eng. 2014;61(6):1765–71.CrossRefPubMed
3.
4.
Davis MJ, Hill MA. “Signaling mechanisms underlying the vascular myogenic response,” (in eng). Physiol Rev. 1999;79(2):387–423.CrossRefPubMed
5.
Schubert R, Lidington D, Bolz SS. “The emerging role of Ca2+ sensitivity regulation in promoting myogenic vasoconstriction,” (in eng). Cardiovasc Res. 2008;77(1):8–18.PubMed
6.
Furchgott RF, Vanhoutte PM. “Endothelium-derived relaxing and contracting factors,” (in eng). FASEB J. 1989;3(9):2007–18.CrossRefPubMed
7.
Tykocki NR, Watts SW. “The interdependence of endothelin-1 and calcium: a review,” (in eng). Clin Sci (Lond). 2010;119(9):361–72.CrossRef
8.
Jankowski V, et al. “Uridine adenosine tetraphosphate: a novel endothelium- derived vasoconstrictive factor,” (in eng). Nat Med. 2005;11(2):223–7.CrossRefPubMed
9.
Majumder K, Wu J. “Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension,” (in eng). Int J Mol Sci. 2014;16(1):256–83.CrossRefPubMedPubMedCentral
10.
Zhou Y, Chen Y, Dirksen WP, Morris M, Periasamy M. “AT1b receptor predominantly mediates contractions in major mouse blood vessels,” (in eng). Circ Res. 2003;93(11):1089–94.CrossRefPubMed
11.
Golino P, et al. “Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators,” (in eng). Circulation. 1989;79(1):154–66.CrossRefPubMed
12.
13.
Tarasova O, Sjöblom-Widfeldt N, Nilsson H. “Transmitter characteristics of cutaneous, renal and skeletal muscle small arteries in the rat,” (in eng). Acta Physiol Scand. 2003;177(2):157–66.CrossRefPubMed
14.
Burnstock G, Ralevic V. “Purinergic signaling and blood vessels in health and disease,” (in eng). Pharmacol Rev. 2014;66(1):102–92.CrossRefPubMed
15.
Burnstock G, Warland JJ. “A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation,” (in eng). Br J Pharmacol. 1987;90(1):111–20.CrossRefPubMedPubMedCentral
16.
Sjöblom-Widfeldt N, Nilsson H. “Sympathetic transmission in small mesenteric arteries from the rat: influence of impulse pattern,” (in eng). Acta Physiol Scand. 1990;138(4):523–8.CrossRefPubMed
17.
18.
Khoshbaten A, Ferrell WR. Nerve-mediated responses of blood-vessels in the rabbit knee-joint. J Vasc Res. 1993;30(2):102–7.CrossRefPubMed
19.
De Mey J, Vanhoutte PM. “Uneven distribution of postjunctional alpha 1-and alpha 2-like adrenoceptors in canine arterial and venous smooth muscle,” (in eng). Circ Res. 1981;48(6 Pt 1):875–84.CrossRefPubMed
20.
MacLennan SJ, Luong LA, Jasper JR, To ZP, Eglen RM. “Characterization of alpha 2-adrenoceptors mediating contraction of dog saphenous vein: identity with the human alpha 2A subtype,” (in eng). Br J Pharmacol. 1997;121(8):1721–9.CrossRefPubMedPubMedCentral
21.
Dunn WR, McGrath JC, Wilson VG. “Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors,” (in eng). Br J Pharmacol. 1991;103(2):1484–92.CrossRefPubMedPubMedCentral
22.
Donoso MV, Steiner M, Huidobro-Toro JP. “BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5′-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed,” (in eng). J Pharmacol Exp Ther. 1997;282(2):691–8.PubMed
23.
Cortés V, et al. “Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226,” (in eng). J Pharmacol Exp Ther. 1999;289(3):1313–22.PubMed
24.
Cheung DW. “Neuropeptide Y Potentiates specifically the purinergic component of the neural responses in the Guinea pig saphenous artery,” (in eng). Circ Res. 1991;68(5):1401–7.CrossRefPubMed
25.
Fabi F, Argiolas L, Ruvolo G, del Basso P. “Neuropeptide Y-Induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane,” (in eng). Br J Pharmacol. 1998;124(1):101–10.CrossRefPubMedPubMedCentral
26.
Paterson G. “The response to transmural stimulation of isolated arterial strips and its modification by drugs,” (in eng). J Pharm Pharmacol. 1965;17:341–9.CrossRefPubMed
27.
Yates CM, Gillis CN. “The response of rabbit vascular tissue to electrical and drug stimulation,” (in eng). J Pharmacol Exp Ther. 1963;140:52–9.PubMed
28.
Furchgott RF. “The pharmacology of vascular smooth muscle,” (in eng). Pharmacol Rev. 1955;7(2):183–265.PubMed
29.
Somlyo AV, Somlyo AP. “Electromechanical and pharmacomechanical coupling in vascular smooth muscle,” (in eng). J Pharmacol Exp Ther. 1968;159(1):129–45.PubMed
30.
31.
Torok J, Zemancikova A. Relaxation of rat main pulmonary artery to electrical stimulation: role of nitric oxide. Act Nerv Super Rediviva. 2010;52(2):151–6.
32.
Guarini S. A highly reproducible model of arterial thrombosis in rats. J Pharmacol Toxicol Methods. 1996;35(2):101–5.CrossRefPubMed
33.
Hladovec J. “Experimental arterial thrombosis in rats with continuous registration,” (in eng). Thromb Diath Haemorrh. Oct 1971;26(2):407–10.PubMedCrossRef
34.
Bourgain RH, F S. A continuous registration method in experimental arterial thrombosis in the rat. Thromb Res. 1974;4:599–607.CrossRefPubMed
35.
Jespersen B, Knupp L, Northcott CA. “Femoral arterial and venous catheterization for blood sampling, drug administration and conscious blood pressure and heart rate measurements,” (in eng). Vis Exp. 2012;(59). doi: https://​doi.​org/​10.​3791/​3496.
36.
Pennes HH. “Analysis of tissue and arterial blood temperatures in the resting human forearm,” (in eng). J Appl Physiol. 1948;1(2):93–122.CrossRefPubMed
37.
Vernier PT, Sun Y, Marcu L, Salemi S, Craft CM, Gundersen MA. “Calcium bursts induced by nanosecond electric pulses,” (in eng). Biochem Biophys Res Commun. 2003;310(2):286–95.CrossRefPubMed
38.
Torres AS, et al. “Platelet activation using electric pulse stimulation: growth factor profile and clinical implications,” (in eng). J Trauma Acute Care Surg. 2014;77(3 Suppl 2):S94–S100.CrossRefPubMed
39.
Frelinger AL, et al. “Modification of pulsed electric field conditions results in distinct activation profiles of platelet-rich plasma,” (in eng). PLoS One. 2016;11(8):e0160933.CrossRefPubMedPubMedCentral
40.
Merrill DR, Marom B, GR JJ. Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J Neurosci Methods. 2005;141(2):171–98.CrossRefPubMed
41.
42.
Zhang W, Edvinsson L, Lee TJ. “Mechanism of nicotine-induced relaxation in the porcine basilar artery,” (in eng). J Pharmacol Exp Ther. 1998;284(2):790–7.PubMed
43.
Tartas M, et al. Cathodal current-induced vasodilation to single application and the amplified response to repeated application in humans rely on aspirin-sensitive mechanisms. J Appl Physiol (1985). 2005;99(4):1538–44.CrossRef
44.
van Mastrigt R, Glerum JJ. “Electrical stimulation of smooth muscle strips from the urinary bladder of the pig,” (in eng). J Biomed Eng. 1985;7(1):2–8.CrossRefPubMed
45.
Burnstock G. “Endothelium-derived vasoconstriction by purines and pyrimidines,” (in eng). Circ Res. 2008;103(10):1056–7.CrossRefPubMed
46.
Yanagisawa M, et al. “A novel potent vasoconstrictor peptide produced by vascular endothelial cells,” (in eng). Nature. 1988;332(6163):411–5.CrossRefPubMed
47.
Lallemand MS, et al. “Resuscitative endovascular balloon occlusion of the aorta for major abdominal venous injury in a porcine hemorrhagic shock model,” (in eng). J Trauma Acute Care Surg. 2017;83(2):230–6.CrossRefPubMed
48.
Weber DG, Bendinelli C, Balogh ZJ. “Damage control surgery for abdominal emergencies,” (in eng). Br J Surg. 2014;101(1):e109–18.CrossRefPubMed
49.
Costantini TW, et al. “Current management of hemorrhage from severe pelvic fractures: results of an American Association for the Surgery of Trauma multi-institutional trial,” (in eng). J Trauma Acute Care Surg. 2016;80(5):717–23; discussion 723–5.CrossRefPubMed
50.
Butterwick A, Vankov A, Huie P, Freyvert Y, Palanker D. Tissue damage by pulsed electrical stimulation. IEEE Trans Biomed Eng. 2007;54(12):2261–7.CrossRefPubMed
51.
Bronzino JD. The biomedical engineering handbook, 2nd ed. (electrical engineering handbook series). Boca Raton, FL: CRC Press; 2000. p. 2. volumes
52.
Duck F. Physical Properties of Tissues: A Comprehensive Reference Book. London: Academic Press; 1990.
53.
Duck FA. Physical properties of tissue : a comprehensive reference book. London: Academic Press; 1990.
54.
K. Giering, I. Lamprecht, and O. Minet, “Specific heat capacities of human and animal tissues,” Proc SPIE 2624, Laser-Tissue Interaction and Tissue Optics, vol. 188, 1996.
55.
Fegler G. “Measurement of cardiac output in anaesthetized animals by a thermodilution method,” (in eng). Q J Exp Physiol Cogn Med Sci. 1954;39(3):153–64.PubMed
56.
Christensen DA. Ultrasonic bioinstrumentation. New York: Wiley; 1988. pp. xiii, 235 pages
Metadata
Title
Mechanisms of electrical vasoconstriction
Authors
Mark Brinton
Yossi Mandel
Ira Schachar
Daniel Palanker
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of NeuroEngineering and Rehabilitation / Issue 1/2018
Electronic ISSN: 1743-0003
DOI
https://doi.org/10.1186/s12984-018-0390-y

Other articles of this Issue 1/2018

Journal of NeuroEngineering and Rehabilitation 1/2018 Go to the issue

Research

Exoskeleton assistance symmetry matters: unilateral assistance reduces metabolic cost, but relatively less than bilateral assistance

Research

Time course of changes in motor-cognitive exergame performances during task-specific training in patients with dementia: identification and predictors of early training response

Research

Speed-adaptive control of functional electrical stimulation for dropfoot correction

Correction

Correction to: Dissociating motor learning from recovery in exoskeleton training post-stroke

Research

Kinect-based assessment of proximal arm non-use after a stroke

Research

Recovery of kinematic arm function in well-performing people with subacute stroke: a longitudinal cohort study